Literature DB >> 25224099

HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping.

Jean-Louis Guéant1, Antonino Romano2, Jose-Antonio Cornejo-Garcia3, Abderrahim Oussalah4, Celine Chery4, Natalia Blanca-López5, Rosa-Maria Guéant-Rodriguez4, Francesco Gaeta6, Pierre Rouyer4, Thomas Josse4, Gabriella Canto5, F David Carmona7, Lara Bossini-Castillo7, Javier Martin7, Jose-Julio Laguna8, Javier Fernandez9, Francisco Feo10, David A Ostrov11, Pablo C Plasencia11, Cristobalina Mayorga12, Maria-Jose Torres12, Miguel Blanca3.   

Abstract

BACKGROUND: Immediate reactions to β-lactams are the most common causes of anaphylactic reactions and can be life-threatening. The few known genetic factors influencing these reactions suggest a link with atopy and inflammation.
OBJECTIVE: We performed a fine-mapping genome-wide association study of the genetic predictors of β-lactam allergy to better understand the underlying mechanisms.
METHODS: We studied 387 patients with immediate allergic reactions to β-lactams and 1124 paired control subjects from Spain. We replicated the results in 299 patients and 362 paired control subjects from Italy.
RESULTS: We found significant associations with the single nucleotide polymorphisms rs4958427 of ZNF300 (c.64-471G>A, P = 9.9 × 10(-9)), rs17612 of C5 (c.4311A>C [p.Glu1437Asp], P = 7.5 × 10(-7)), rs7754768 and rs9268832 of the HLA-DRA | HLA-DRB5 interregion (P = 1.6 × 10(-6) and 4.9 × 10(-6)), and rs7192 of HLA-DRA (c.724T>G [p.Leu242Val], P = 7.4 × 10(-6)) in an allelic model, with similar results in an additive model. Single nucleotide polymorphisms of HLA-DRA and ZNF300 predicted skin test positivity to amoxicillin and other penicillins but not to cephalosporins. A haplotype block in HLA-DRA and the HLA-DRA | HLA-DRB5 interregion encompassed a motif involved in balanced expression of the α- and β-chains of MHC class II, whereas rs7192 was predicted to influence α-chain conformation. HLA-DRA rs7192 and rs8084 were significantly associated with allergy to penicillins and amoxicillin (P = 6.0 × 10(-4) and P = 4.0 × 10(-4), respectively) but not to cephalosporins in the replication study.
CONCLUSIONS: Gene variants of HLA-DRA and the HLA-DRA | HLA-DRB5 interregion were significant predictors of allergy to penicillins but not to cephalosporins. These data suggest complex gene-environment interactions in which genetic susceptibility of HLA type 2 antigen presentation plays a central role.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Entities:  

Keywords:  Drug allergy; HLA-DRA; amoxicillin; anaphylaxis; genome-wide association; immediate-type reactions; penicillins; β-lactams

Mesh:

Substances:

Year:  2014        PMID: 25224099     DOI: 10.1016/j.jaci.2014.07.047

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

Review 1.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

2.  A non-synonymous polymorphism in galectin-3 lectin domain is associated with allergic reactions to beta-lactam antibiotics.

Authors:  J A Cornejo-García; A Romano; R M Guéant-Rodríguez; A Oussalah; N Blanca-López; F Gaeta; D Tramoy; T Josse; I Doña; M J Torres; G Canto; M Blanca; J-L Guéant
Journal:  Pharmacogenomics J       Date:  2015-04-14       Impact factor: 3.550

Review 3.  Cross-Reactivity among Beta-Lactams.

Authors:  Antonino Romano; Francesco Gaeta; Maria Francisca Arribas Poves; Rocco Luigi Valluzzi
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

4.  Correlation analysis of gene polymorphisms and β-lactam allergy.

Authors:  Jing Li; Xin-yue Liu; Lin-jing Li; Chong-ge You; Lei Shi; Shang-di Zhang; Qian Liu; Jun Wang; Ze-jing Liu; Ting-hong Lv
Journal:  J Zhejiang Univ Sci B       Date:  2015-07       Impact factor: 3.066

Review 5.  Pharmacogenomics of off-target adverse drug reactions.

Authors:  Sarah L Garon; Rebecca K Pavlos; Katie D White; Nancy J Brown; Cosby A Stone; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2017-04-27       Impact factor: 4.335

Review 6.  New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.

Authors:  Munir Pirmohamed; David A Ostrov; B Kevin Park
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

Review 7.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

Review 8.  Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

Authors:  Katie D White; Wen-Hung Chung; Shuen-Iu Hung; Simon Mallal; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

9.  A splice acceptor variant in HLA-DRA affects the conformation and cellular localization of the class II DR alpha-chain.

Authors:  Alessandro Didonna; Vincent Damotte; Hengameh Shams; Atsuko Matsunaga; Stacy J Caillier; Ravi Dandekar; Maneesh K Misra; Mohammad R K Mofrad; Jorge R Oksenberg; Jill A Hollenbach
Journal:  Immunology       Date:  2020-10-19       Impact factor: 7.397

10.  Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort.

Authors:  Paola Nicoletti; Daniel F Carr; Sarah Barrett; Laurence McEvoy; Peter S Friedmann; Neil H Shear; Matthew R Nelson; Anca M Chiriac; Natalia Blanca-López; José A Cornejo-García; Francesco Gaeta; Alla Nakonechna; Maria J Torres; Cristiano Caruso; Rocco L Valluzzi; Aris Floratos; Yufeng Shen; Rebecca K Pavlos; Elizabeth J Phillips; Pascal Demoly; Antonino Romano; Miguel Blanca; Munir Pirmohamed
Journal:  J Allergy Clin Immunol       Date:  2020-10-13       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.